PI3K/Akt signaling has been shown to be activated in a variety of cancers and activated Akt acts to phosphorylate Bad and Caspase-9 or activate NF-κB pathway to promote the resistance of cancer cells to apoptosis [21–24]. Here, BAD is linked to cancer.